[1] |
LAMMERT F, GURUSAMY K, KO CW, et al. Gallstones[J]. Nat Rev Dis Primers, 2016, 2: 16024. DOI: 10.1038/nrdp.2016.24.
|
[2] |
PORTINCASA P, MOSCHETTA A, PALASCIANO G. Cholesterol gallstone disease[J]. Lancet, 2006, 368( 9531): 230- 239. DOI: 10.1016/s0140-6736(06)69044-2.
|
[3] |
SONG ST, SHI J, WANG XH, et al. Prevalence and risk factors for gallstone disease: A population-based cross-sectional study[J]. J Dig Dis, 2020, 21( 4): 237- 245. DOI: 10.1111/1751-2980.12857.
|
[4] |
WANG F, WANG J, LI YR, et al. Gallstone disease and type 2 diabetes risk: A Mendelian randomization study[J]. Hepatology, 2019, 70( 2): 610- 620. DOI: 10.1002/hep.30403.
|
[5] |
PANG YJ, LV J, KARTSONAKI C, et al. Causal effects of gallstone disease on risk of gastrointestinal cancer in Chinese[J]. Br J Cancer, 2021, 124( 11): 1864- 1872. DOI: 10.1038/s41416-021-01325-w.
|
[6] |
SHABANZADEH DM, SKAABY T, SØRENSEN LT, et al. Screen-detected gallstone disease and cardiovascular disease[J]. Eur J Epidemiol, 2017, 32( 6): 501- 510. DOI: 10.1007/s10654-017-0263-x.
|
[7] |
SHABANZADEH DM, SØRENSEN LT, JØRGENSEN T. Gallstone disease and mortality: A cohort study[J]. Int J Public Health, 2017, 62( 3): 353- 360. DOI: 10.1007/s00038-016-0916-7.
|
[8] |
SHABANZADEH DM. Incidence of gallstone disease and complications[J]. Curr Opin Gastroenterol, 2018, 34( 2): 81- 89. DOI: 10.1097/MOG.0000000000000418.
|
[9] |
SHAFFER EA. Gallstone disease: Epidemiology of gallbladder stone disease[J]. Best Pract Res Clin Gastroenterol, 2006, 20( 6): 981- 996. DOI: 10.1016/j.bpg.2006.05.004.
|
[10] |
LIN IC, YANG YW, WU MF, et al. The association of metabolic syndrome and its factors with gallstone disease[J]. BMC Fam Pract, 2014, 15: 138. DOI: 10.1186/1471-2296-15-138.
|
[11] |
HUNG MC, CHEN CF, TSOU MT, et al. Relationship between gallstone disease and cardiometabolic risk factors in elderly people with non-alcoholic fatty liver disease[J]. Diabetes Metab Syndr Obes, 2020, 13: 3579- 3585. DOI: 10.2147/DMSO.S266947.
|
[12] |
ALMOBARAK AO, JERVASE A, FADL AA, et al. The prevalence of diabetes and metabolic syndrome and associated risk factors in Sudanese individuals with gallstones: A cross sectional survey[J]. Transl Gastroenterol Hepatol, 2020, 5: 14. DOI: 10.21037/tgh.2019.10.09.
|
[13] |
CHANG Y, NOH YH, SUH BS, et al. Bidirectional association between nonalcoholic fatty liver disease and gallstone disease: A cohort study[J]. J Clin Med, 2018, 7( 11): 458. DOI: 10.3390/jcm7110458.
|
[14] |
WANIEK S, DI GIUSEPPE R, ESATBEYOGLU T, et al. Association of circulating vitamin E(α- and γ-tocopherol) levels with gallstone disease[J]. Nutrients, 2018, 10( 2): 133. DOI: 10.3390/nu10020133.
|
[15] |
WANG JW, SHEN S, WANG B, et al. Serum lipid levels are the risk factors of gallbladder stones: A population-based study in China[J]. Lipids Health Dis, 2020, 19( 1): 50. DOI: 10.1186/s12944-019-1184-3.
|
[16] |
WALCHER T, HAENLE MM, KRON M, et al. Vitamin C supplement use may protect against gallstones: An observational study on a randomly selected population[J]. BMC Gastroenterol, 2009, 9: 74. DOI: 10.1186/1471-230X-9-74.
|
[17] |
STROUP DF, BERLIN JA, MORTON SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology(MOOSE) group[J]. JAMA, 2000, 283( 15): 2008- 2012. DOI: 10.1001/jama.283.15.2008.
|
[18] |
HIGGINS JPT, THOMPSON SG. Quantifying heterogeneity in a meta-analysis[J]. Stat Med, 2002, 21( 11): 1539- 1558. DOI: 10.1002/sim.1186.
|
[19] |
BROK J, THORLUND K, GLUUD C, et al. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses[J]. J Clin Epidemiol, 2008, 61( 8): 763- 769. DOI: 10.1016/j.jclinepi.2007.10.007.
|
[20] |
GONZÁLEZ-PÉREZ A, GARCÍA RODRÍGUEZ LA. Gallbladder disease in the general population: Association with cardiovascular morbidity and therapy[J]. Pharmacoepidemiol Drug Saf, 2007, 16( 5): 524- 531. DOI: 10.1002/pds.1346.
|
[21] |
CHATTERJEE S, WETTERSLEV J, SHARMA A, et al. Association of blood transfusion with increased mortality in myocardial infarction: A meta-analysis and diversity-adjusted study sequential analysis[J]. JAMA Intern Med, 2013, 173( 2): 132- 139. DOI: 10.1001/2013.jamainternmed.1001.
|
[22] |
BOLAND LL, FOLSOM AR, ROSAMOND WD, et al. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study[J]. Ann Epidemiol, 2002, 12( 2): 131- 140. DOI: 10.1016/s1047-2797(01)00260-5.
|
[23] |
WEI W, LI Y, CHEN F, et al. Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women[J]. J Hum Hypertens, 2011, 25( 6): 364- 371. DOI: 10.1038/jhh.2010.67.
|
[24] |
HAN TS, LAN L, QU RG, et al. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension[J]. Hypertension, 2017, 70( 4): 703- 711. DOI: 10.1161/HYPERTENSIONAHA.117.09508.
|
[25] |
WANG F, HAN LL, HU DY. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis[J]. Clin Chim Acta, 2017, 464: 57- 63. DOI: 10.1016/j.cca.2016.11.009.
|
[26] |
CORTÉS VA, BARRERA F, NERVI F. Pathophysiological connections between gallstone disease, insulin resistance, and obesity[J]. Obes Rev, 2020, 21( 4): e12983. DOI: 10.1111/obr.12983.
|
[27] |
JANOWITZ P, WECHSLER JG, KUHN K, et al. The relationship between serum lipids, nucleation time, and biliary lipids in patients with gallstones[J]. Clin Investig, 1992, 70( 5): 430- 436. DOI: 10.1007/BF00235527.
|
[28] |
SCRAGG RK, CALVERT GD, OLIVER JR. Plasma lipids and insulin in gall stone disease: A case-control study[J]. Br Med J(Clin Res Ed), 1984, 289( 6444): 521- 525. DOI: 10.1136/bmj.289.6444.521.
|
[29] |
HUSSAINI SH, PEREIRA SP, MURPHY GM, et al. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile[J]. Hepatology, 1995, 22( 6): 1735- 1744.
|
[30] |
RUHL CE, EVERHART JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease[J]. Hepatology, 2000, 31( 2): 299- 303. DOI: 10.1002/hep.510310206.
|
[31] |
SHANKAR A, XIAO J. Positive relationship between plasma leptin level and hypertension[J]. Hypertension, 2010, 56( 4): 623- 628. DOI: 10.1161/HYPERTENSIONAHA.109.148213.
|
[32] |
SARAÇ S, ATAMER A, ATAMER Y, et al. Leptin levels and lipoprotein profiles in patients with cholelithiasis[J]. J Int Med Res, 2015, 43( 3): 385- 392. DOI: 10.1177/0300060514561134.
|
[33] |
ZHANG YY, CHUA S Jr. Leptin function and regulation[J]. Compr Physiol, 2017, 8( 1): 351- 369. DOI: 10.1002/cphy.c160041.
|
[34] |
WANG SN, YEH YT, YU ML, et al. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease[J]. Eur J Clin Invest, 2006, 36( 3): 176- 180. DOI: 10.1111/j.1365-2362.2006.01611.x.
|
[35] |
KAZE AD, MUSANI SK, BIDULESCU A, et al. Plasma leptin and blood pressure progression in blacks: The Jackson heart study[J]. Hypertension, 2021, 77( 4): 1069- 1075. DOI: 10.1161/HYPERTENSIONAHA.120.16174.
|
[36] |
ROY S, HYOGO H, YADAV SK, et al. A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse[J]. Hepatology, 2005, 41( 4): 887- 895. DOI: 10.1002/hep.20643.
|
[37] |
HYOGO H, ROY S, PAIGEN B, et al. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts[J]. J Biol Chem, 2002, 277( 37): 34117- 34124. DOI: 10.1074/jbc.M203912200.
|
[38] |
VANPATTEN S, RANGINANI N, SHEFER S, et al. Impaired biliary lipid secretion in obese Zucker rats: Leptin promotes hepatic cholesterol clearance[J]. Am J Physiol Gastrointest Liver Physiol, 2001, 281( 2): G393- G404. DOI: 10.1152/ajpgi.2001.281.2.G393.
|
[39] |
CHOOI YC, DING C, MAGKOS F. The epidemiology of obesity[J]. Metabolism, 2019, 92: 6- 10. DOI: 10.1016/j.metabol.2018.09.005.
|
[40] |
FRANKLIN SS, 4th GUSTIN W, WONG ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study[J]. Circulation, 1997, 96( 1): 308- 315. DOI: 10.1161/01.cir.96.1.308.
|
[41] |
WANG HH, LIU M, CLEGG DJ, et al. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation[J]. Biochim Biophys Acta, 2009, 1791( 11): 1037- 1047. DOI: 10.1016/j.bbalip.2009.06.006.
|
[42] |
SHABANZADEH DM, SØRENSEN LT, JØRGENSEN T. Determinants for gallstone formation- a new data cohort study and a systematic review with meta-analysis[J]. Scand J Gastroenterol, 2016, 51( 10): 1239- 1248. DOI: 10.1080/00365521.2016.1182583.
|
[43] |
ZHANG C, HU SL, SUN P, et al. Prevalence of gallstones among university teachers and related risk factors: A multicenter study[J]. J Clin Hepatol, 2020, 36( 3): 624- 630. DOI: 10.3969/j.issn.1001-5256.2020.03.031.
张弛, 胡舒铃, 孙鹏, 等. 大学教师胆结石患病现状及危险因素的多中心研究[J]. 临床肝胆病杂志, 2020, 36( 3): 624- 630. DOI: 10.3969/j.issn.1001-5256.2020.03.031.
|
[44] |
GRÜNHAGE F, ACALOVSCHI M, TIRZIU S, et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol[J]. Hepatology, 2007, 46( 3): 793- 801. DOI: 10.1002/hep.21847.
|
[45] |
STENDER S, FRIKKE-SCHMIDT R, NORDESTGAARD BG, et al. The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease[J]. J Am Coll Cardiol, 2014, 63( 20): 2121- 2128. DOI: 10.1016/j.jacc.2013.12.055.
|
[46] |
HUESCA-GÓMEZ C, TORRES-PAZ YE, MARTÍNEZ-ALVARADO R, et al. Association between the transporters ABCA1/G1 and the expression of miR-33a/144 and the carotid intima media thickness in patients with arterial hypertension[J]. Mol Biol Rep, 2020, 47( 2): 1321- 1329. DOI: 10.1007/s11033-019-05229-0.
|
[47] |
ZHANG N, JIA J, DING QJ, et al. Common variant rs11191548 near the CYP17A1 gene is associated with hypertension and the serum 25(OH) D levels in Han Chinese[J]. J Hum Genet, 2018, 63( 6): 731- 737. DOI: 10.1038/s10038-018-0435-x.
|
[48] |
ZHANG N, CHEN HM, JIA J, et al. The CYP17A1 gene polymorphisms are associated with hypercholesterolemia in Han Chinese[J]. J Gene Med, 2019, 21( 8): e3102. DOI: 10.1002/jgm.3102.
|
[49] |
PUPPALA S, DODD GD, FOWLER S, et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans[J]. Am J Hum Genet, 2006, 78( 3): 377- 392. DOI: 10.1086/500274.
|